It is possible that the growth-promoting MAPK pathway, which predominates in vascular SMCs and is hypothesized to be unaffected or even potentiated by hyperinsulinemia in conditions of insulin resistance [15], was not activated by insulin in our in vivo conditions. The gene discussed is INS; the disease is Hyperinsulinemia.